<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39339970</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Validation of Saliva as the Clinical Specimen Type for a University-Wide COVID-19 Surveillance Program.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1494</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16091494</ELocationID><Abstract><AbstractText>At the beginning of the COVID-19 pandemic, the Georgia Institute of Technology made the decision to keep the university doors open for on-campus attendance. To manage COVID-19 infection rates, internal resources were applied to develop and implement a mass asymptomatic surveillance program. The objective was to identify infections early for proper follow-on verification testing, contact tracing, and quarantine/isolation as needed. Program success depended on frequent and voluntary sample collection from over 40,000 students, faculty, and staff personnel. At that time, the nasopharyngeal (NP) swab, not saliva, was the main accepted sample type for COVID-19 testing. However, due to collection discomfort and the inability to be self-collected, the NP swab was not feasible for voluntary and frequent self-collection. Therefore, saliva was selected as the clinical sample type and validated. A saliva collection kit and a sample processing and analysis workflow were developed. The results of a clinical sample-type comparison study between co-collected and matched NP swabs and saliva samples showed 96.7% positive agreement and 100% negative agreement. During the Fall 2020 and Spring 2021 semesters, 319,988 samples were collected and tested. The program resulted in maintaining a low overall mean positivity rate of 0.78% and 0.54% for the Fall 2020 and Spring 2021 semesters, respectively. For this high-throughput asymptomatic COVID-19 screening application, saliva was an exceptionally good sample type.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farrell</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0001-6051-7798</Identifier><AffiliationInfo><Affiliation>Advanced Concepts Lab, Georgia Tech Research Institute, Atlanta, GA 30318, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bryksin</LastName><ForeName>Anton V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9653-9160</Identifier><AffiliationInfo><Affiliation>Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Djeddar</LastName><ForeName>Naima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khunteev</LastName><ForeName>German</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holton</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Stamps Student Health Services, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paca</LastName><ForeName>Miles</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Advanced Concepts Lab, Georgia Tech Research Institute, Atlanta, GA 30318, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Speller</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Advanced Concepts Lab, Georgia Tech Research Institute, Atlanta, GA 30318, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merrill</LastName><ForeName>James T</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0009-0005-2640-9407</Identifier><AffiliationInfo><Affiliation>Advanced Concepts Lab, Georgia Tech Research Institute, Atlanta, GA 30318, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Ted M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0003-1947-7469</Identifier><AffiliationInfo><Affiliation>Animal Health Research Center, Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogan</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-0225-830X</Identifier><AffiliationInfo><Affiliation>Animal Health Research Center, Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>Greg</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5352-5877</Identifier><AffiliationInfo><Affiliation>Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García</LastName><ForeName>Andrés J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0001-6602-2518</Identifier><AffiliationInfo><Affiliation>Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shannon</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Advanced Concepts Lab, Georgia Tech Research Institute, Atlanta, GA 30318, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of the President, University of North Georgia, Dahlonega, GA 30597, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="Y">Saliva</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013048" MajorTopicYN="Y">Specimen Handling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014495" MajorTopicYN="N">Universities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="Y">Nasopharynx</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005845" MajorTopicYN="N" Type="Geographic">Georgia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">RNA</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">nasopharyngeal swap</Keyword><Keyword MajorTopicYN="N">saliva</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39339970</ArticleId><ArticleId IdType="pmc">PMC11437455</ArticleId><ArticleId IdType="doi">10.3390/v16091494</ArticleId><ArticleId IdType="pii">v16091494</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bedford J., Enria D., Giesecke J., Heymann D.L., Ihekweazu C., Kobinger G., Lane H.C., Memish Z., Oh M.D., Schuchat A., et al. COVID-19: Towards controlling of a pandemic. Lancet. 2020;395:1015–1018. doi: 10.1016/S0140-6736(20)30673-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30673-5</ArticleId><ArticleId IdType="pmc">PMC7270596</ArticleId><ArticleId IdType="pubmed">32197103</ArticleId></ArticleIdList></Reference><Reference><Citation>Methi F., Henie Madslien E. Lower transmissibility of SARS-CoV-2 among asymptomatic cases: Evidence from contact tracing data in Oslo, Norway. BMC Med. 2022;20:427. doi: 10.1186/s12916-022-02642-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02642-4</ArticleId><ArticleId IdType="pmc">PMC9641677</ArticleId><ArticleId IdType="pubmed">36348327</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M.A., Quandelacy T.M., Kada S., Venkata Prasad P., Steele M., Brooks J.T., Slayton R.B., Biggerstaff M., Butler J.C. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Network Open. 2021;4:e2035057. doi: 10.1001/jamanetworkopen.2020.35057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.35057</ArticleId><ArticleId IdType="pmc">PMC7791354</ArticleId><ArticleId IdType="pubmed">33410879</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopman B., Liu C.Y., Le Guillou A., Handel A., Lash T.L., Isakov A.P., Jenness S.M. A modeling study to inform screening and testing interventions for the control of SARS-CoV-2 on university campuses. Sci. Rep. 2021;11:5900. doi: 10.1038/s41598-021-85252-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85252-z</ArticleId><ArticleId IdType="pmc">PMC7960702</ArticleId><ArticleId IdType="pubmed">33723312</ArticleId></ArticleIdList></Reference><Reference><Citation>Panovska-Griffiths J., Kerr G.C., Stuart R.M., Mistry D., Klein D.J., Viner R.M., Bonell C. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: A modelling study. Lancet Child Adolesc. Health. 2020;4:817–827. doi: 10.1016/S2352-4642(20)30250-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30250-9</ArticleId><ArticleId IdType="pmc">PMC7398659</ArticleId><ArticleId IdType="pubmed">32758453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali F., Sweeney D.A. No one likes a stick up their nose: Making the case for saliva-based testing for COVID-19. Clin. Infect. Dis. 2020;72:e357–e358. doi: 10.1093/cid/ciaa1314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1314</ArticleId><ArticleId IdType="pmc">PMC7499553</ArticleId><ArticleId IdType="pubmed">32875330</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson K.E., Barker A.P., Hillyard D.R., Gilmore N., Barrett J.W., Orlandi R.R., Shakir S.M. Self-collected anterior nasal and saliva specimens versus health care worker-collected nasopharyngeal swabs for the molecular detection of SARS-CoV-2. J. Clin. Microbiol. 2020;58:e01824-20. doi: 10.1128/JCM.01824-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01824-20</ArticleId><ArticleId IdType="pmc">PMC7587122</ArticleId><ArticleId IdType="pubmed">32817233</ArticleId></ArticleIdList></Reference><Reference><Citation>Landry M.L., Criscuolo J., Peaper D.R. Challenges in use of saliva for detection of SARS-CoV-2 RNA in symptomatic outpatients. J. Clin. Virol. 2020;130:e104567. doi: 10.1016/j.jcv.2020.104567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104567</ArticleId><ArticleId IdType="pmc">PMC7392849</ArticleId><ArticleId IdType="pubmed">32750665</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.K., Chen Z., Lui G., Ling L., Li T., Wong M., Ng R.W., Tso E.Y., Ho T., Fung K.S., et al. Prospective study comparing deep-throat saliva with other respiratory tract specimens in the diagnosis of novel coronavirus disease (COVID-19) J. Infect. Dis. 2020;222:1612–1619. doi: 10.1093/infdis/jiaa487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa487</ArticleId><ArticleId IdType="pmc">PMC7454747</ArticleId><ArticleId IdType="pubmed">32738137</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal A.J., Mohammad M., Coomes E., Powis J., Li A., Paterson A., Anceva-Sami S., Barati S., Crowl G., Faheem A., et al. Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin. Infect. Dis. 2021;72:1064–1066. doi: 10.1093/cid/ciaa848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa848</ArticleId><ArticleId IdType="pmc">PMC7337630</ArticleId><ArticleId IdType="pubmed">32584972</ArticleId></ArticleIdList></Reference><Reference><Citation>Fakheran O., Dehghannejad M., Khademi A. Saliva as a diagnostic specimen for detection of SARS-CoV-2 in suspected patients: A scoping review. Infect. Dis. Poverty. 2020;9:100. doi: 10.1186/s40249-020-00728-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00728-w</ArticleId><ArticleId IdType="pmc">PMC7374661</ArticleId><ArticleId IdType="pubmed">32698862</ArticleId></ArticleIdList></Reference><Reference><Citation>Czumbel L.M., Kiss S., Farkas N., Mandel I., Hegyi P., Steward M.C., Varga G. Saliva as a candidate for COVID-19 diagnostic testing: A meta-analysis. Front. Med. 2020;7:465. doi: 10.3389/fmed.2020.00465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00465</ArticleId><ArticleId IdType="pmc">PMC7438940</ArticleId><ArticleId IdType="pubmed">32903849</ArticleId></ArticleIdList></Reference><Reference><Citation>To K.K., Tsang O.T., Leung W.S., Tam A.R., Wu T.C., Lung D.C., Yip C.C., Cai J.P., Chan J.M., Chik T.S., et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study. Lancet Infect. Dis. 2020;20:565–574. doi: 10.1016/S1473-3099(20)30196-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30196-1</ArticleId><ArticleId IdType="pmc">PMC7158907</ArticleId><ArticleId IdType="pubmed">32213337</ArticleId></ArticleIdList></Reference><Reference><Citation>To K.K., Tsang O.T., Yip C.C., Chan K.H., Wu T.C., Chan J.M., Leung W.S., Chik T.S., Choi C.Y., Kandamby D.H., et al. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. 2020;71:841–843. doi: 10.1093/cid/ciaa149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa149</ArticleId><ArticleId IdType="pmc">PMC7108139</ArticleId><ArticleId IdType="pubmed">32047895</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzi L., Carcano G., Gianfagna F., Grossi P., Dalla Gasperina D., Genoni A., Fasano M., Sessa F., Tettamanti L., Carinci F., et al. Saliva is a reliable tool to detect SARS-CoV-2. J. Infect. 2020;81:e45–e50. doi: 10.1016/j.jinf.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.005</ArticleId><ArticleId IdType="pmc">PMC7194805</ArticleId><ArticleId IdType="pubmed">32298676</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon J.G., Yoon J., Song J.Y., Yoon S.Y., Lim C.S., Seong H., Noh J.Y., Cheong H.J., Kim W.J. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J. Korean Med. Sci. 2020;35:e195. doi: 10.3346/jkms.2020.35.e195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e195</ArticleId><ArticleId IdType="pmc">PMC7246183</ArticleId><ArticleId IdType="pubmed">32449329</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyllie A.L., Fournier J., Casanovas-Massana A., Campbell M., Tokuyama M., Vijayakumar P., Warren J.L., Geng B., Muenker M.C., Moore A.J., et al. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N. Engl. J. Med. 2020;33:1283–1286. doi: 10.1056/NEJMc2016359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2016359</ArticleId><ArticleId IdType="pmc">PMC7484747</ArticleId><ArticleId IdType="pubmed">32857487</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson G., Weitz S., Shannon M.P., Holton B., Bryksin A., Liu B., Sieglinger M., Coenen A.R., Zhou C., Beckett S.J., et al. Surveillance-to-diagnostic testing program for asymptomatic SARS-CoV-2 infections on a large urban campus in fall 2020. Epidemiology. 2021;33:209–216. doi: 10.1097/EDE.0000000000001448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000001448</ArticleId><ArticleId IdType="pubmed">34860727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., Wang L., Sakthivel S.K., Whitaker B., Murray J., Kamili S., Lynch B., Malapati L., Burke S.A., Harcourt J., et al. US CDC real-time reverse transcription PCR panel for detection of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg. Infect. Dis. 2020;8:1654–1665. doi: 10.3201/eid2608.201246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.201246</ArticleId><ArticleId IdType="pmc">PMC7392423</ArticleId><ArticleId IdType="pubmed">32396505</ArticleId></ArticleIdList></Reference><Reference><Citation>Atieh M.A., Guirguis M., Alsabeeha N.H.M., Cannon D.C. The diagnostic accuracy of saliva testing for SARS-CoV-2: A systematic review and meta-analysis. Oral Dis. 2021;28:2347–2361. doi: 10.1111/odi.13934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.13934</ArticleId><ArticleId IdType="pmc">PMC8242702</ArticleId><ArticleId IdType="pubmed">34080272</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahajpal N.S., Mondal A.K., Ananth S., Njau A., Ahluwalia P., Kota V., Caspary K., Ross T.M., Farrell M., Shannon P., et al. Clinical validation of a sensitive test for saliva collected in healthcare and community settings with pooling utility for severed acute respiratory syndrome coronavirus 2 mass surveillance. J. Mol. Diagn. 2021;23:788–795. doi: 10.1016/j.jmoldx.2021.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2021.04.005</ArticleId><ArticleId IdType="pmc">PMC8129802</ArticleId><ArticleId IdType="pubmed">33957320</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>